Breakthrough Decade: Heavy Ion Cancer Tech Reaches Global Stage via Wuwei Model Marking Five Years
After five years of refinement and operation in western China, the nation’s first domestically produced heavy ion therapy system now stands as a mature testament to the rise of China’s high-end medical equipment. On June 28, the "Wuwei Heavy Ion Center’s 5th Anniversary & Academic Symposium on Cutting-Edge Ion Therapy Technologies" concluded successfully in Wuwei, Gansu. This grand event not only celebrated the achievements of the past five years but also proclaimed to the world that China’s fully independent heavy ion cancer therapy technology has been successfully implemented in the western region, benefiting patients and demonstrating its readiness for the global stage.
A Decade of Cultivation, A Harvest of Achievements. Commencing construction in May 2012 and launching clinical operations in March 2020, the Gansu Wuwei Heavy Ion Center has now operated for over five years. As the nation’s first domestically developed heavy ion therapy system in clinical use, its establishment in Wuwei—a city in western China—carries profound significance. This "national treasure" (Zhī Guózhīzhòngqì) has not only filled a critical gap in China’s high-end medical capabilities but has also established China as a paradigm for developing world-class medical facilities in regions with limited healthcare resources, driving rapid advancements in regional healthcare standards and propelling the Healthy China initiative in the west.
The 5th-anniversary symposium brought together over a hundred top experts in medical heavy ion R&D, production, and clinical application, including academicians Zhan Wenlong (Chinese Academy of Sciences), Xia Jiawen, Yang Yongping, and Ma Jun (Chinese Academy of Engineering), as well as Prof. Wang Junjie, Chairman of the Oncology Therapy Committee of the Chinese Medical Association. Notably, expert teams from Japan, Singapore, and Vietnam also attended. This convergence of global expertise not only endorsed Wuwei Center’s achievements but clearly signaled: China’s heavy ion technology is now fully autonomous, stable, and globally competitive, poised to serve patients worldwide.
Prof. Tang Jintian of Tsinghua University, leading the university’s Advanced Particle Industry Development platform team, congratulated the Center on its success, hailing it as "a landmark milestone in China’s high-end medical equipment history" that brings honor especially to western China. He pledged continued support for regional advancement, deeper industry-academia collaboration, and greater contributions to the Healthy China strategy.
These five years mark the critical transition of China’s heavy ion technology from lab to clinic—a triumph not only of technology but of national strategy realized in the west. With the matured "Wuwei Model" and the clarion call sounded at this symposium, China's heavy ion technology is now confidently embarking on a global journey, poised to contribute Chinese expertise and solutions to the worldwide fight against cancer.